 Matthew Stone
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 9 | 2026 | 680 | 3.330 |
Why?
| | Cardiac Surgical Procedures | 12 | 2025 | 611 | 3.070 |
Why?
| | Fontan Procedure | 8 | 2026 | 192 | 2.790 |
Why?
| | Heart Defects, Congenital | 10 | 2026 | 910 | 2.550 |
Why?
| | Heart Septal Defects, Ventricular | 3 | 2022 | 45 | 1.810 |
Why?
| | Blood Group Incompatibility | 2 | 2025 | 21 | 1.750 |
Why?
| | ABO Blood-Group System | 2 | 2025 | 58 | 1.680 |
Why?
| | Ventricular Function, Left | 8 | 2024 | 544 | 1.540 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2024 | 394 | 1.450 |
Why?
| | Ventricular Outflow Obstruction | 2 | 2022 | 38 | 1.440 |
Why?
| | Computed Tomography Angiography | 2 | 2023 | 146 | 1.400 |
Why?
| | Aortic Diseases | 3 | 2022 | 125 | 1.360 |
Why?
| | Patient Selection | 2 | 2026 | 739 | 1.350 |
Why?
| | Double Outlet Right Ventricle | 2 | 2022 | 9 | 1.320 |
Why?
| | Abnormalities, Multiple | 2 | 2025 | 199 | 1.300 |
Why?
| | Predictive Value of Tests | 4 | 2024 | 2123 | 1.230 |
Why?
| | Heart Ventricles | 7 | 2026 | 756 | 1.190 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 256 | 1.180 |
Why?
| | Hypoplastic Left Heart Syndrome | 4 | 2024 | 119 | 1.120 |
Why?
| | Hemodynamics | 6 | 2025 | 1118 | 1.020 |
Why?
| | Myocardial Contraction | 3 | 2025 | 293 | 1.000 |
Why?
| | Perfusion | 3 | 2025 | 251 | 0.990 |
Why?
| | Pulmonary Atresia | 2 | 2025 | 23 | 0.950 |
Why?
| | Cigarette Smoking | 2 | 2025 | 102 | 0.930 |
Why?
| | Sphingosine | 1 | 2025 | 47 | 0.850 |
Why?
| | Postoperative Complications | 8 | 2025 | 2977 | 0.850 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2025 | 52 | 0.850 |
Why?
| | Lysophospholipids | 1 | 2025 | 80 | 0.830 |
Why?
| | Mitochondria, Heart | 1 | 2025 | 107 | 0.820 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2025 | 139 | 0.810 |
Why?
| | Allografts | 1 | 2024 | 152 | 0.780 |
Why?
| | Pulmonary Valve | 1 | 2025 | 102 | 0.780 |
Why?
| | Infant | 13 | 2025 | 10091 | 0.770 |
Why?
| | Central Venous Catheters | 2 | 2022 | 53 | 0.770 |
Why?
| | Aortic Coarctation | 1 | 2023 | 78 | 0.750 |
Why?
| | Coronary Circulation | 2 | 2022 | 134 | 0.750 |
Why?
| | Fibroma | 1 | 2022 | 21 | 0.730 |
Why?
| | Tissue and Organ Procurement | 2 | 2025 | 343 | 0.720 |
Why?
| | Atrioventricular Block | 1 | 2022 | 44 | 0.720 |
Why?
| | Heart Neoplasms | 1 | 2022 | 56 | 0.710 |
Why?
| | Catheterization, Central Venous | 2 | 2022 | 123 | 0.710 |
Why?
| | Child | 22 | 2025 | 22740 | 0.690 |
Why?
| | Aorta, Thoracic | 2 | 2023 | 287 | 0.690 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.660 |
Why?
| | Graft Rejection | 1 | 2024 | 521 | 0.650 |
Why?
| | Coronary Vessels | 1 | 2022 | 246 | 0.640 |
Why?
| | Echocardiography | 1 | 2023 | 648 | 0.640 |
Why?
| | Coronary Angiography | 1 | 2022 | 328 | 0.640 |
Why?
| | Retrospective Studies | 16 | 2025 | 17330 | 0.610 |
Why?
| | Humans | 58 | 2026 | 145783 | 0.600 |
Why?
| | Child, Preschool | 12 | 2025 | 11868 | 0.590 |
Why?
| | Treatment Outcome | 16 | 2025 | 11794 | 0.590 |
Why?
| | Vena Cava, Inferior | 2 | 2024 | 83 | 0.590 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 329 | 0.590 |
Why?
| | Infant, Newborn | 11 | 2025 | 6465 | 0.590 |
Why?
| | Vascular Stiffness | 2 | 2020 | 487 | 0.570 |
Why?
| | Primary Graft Dysfunction | 1 | 2019 | 33 | 0.560 |
Why?
| | Male | 35 | 2025 | 73011 | 0.550 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2018 | 27 | 0.540 |
Why?
| | Waiting Lists | 3 | 2025 | 266 | 0.540 |
Why?
| | Septal Occluder Device | 1 | 2018 | 37 | 0.540 |
Why?
| | Nicardipine | 1 | 2017 | 6 | 0.530 |
Why?
| | Laparoscopy | 2 | 2012 | 481 | 0.500 |
Why?
| | Calcium Channel Blockers | 1 | 2017 | 166 | 0.490 |
Why?
| | Cardiac Catheterization | 3 | 2022 | 559 | 0.490 |
Why?
| | Lung Transplantation | 2 | 2017 | 332 | 0.490 |
Why?
| | Shock | 1 | 2017 | 110 | 0.480 |
Why?
| | Reperfusion Injury | 2 | 2017 | 292 | 0.450 |
Why?
| | Extracellular Vesicles | 1 | 2017 | 171 | 0.440 |
Why?
| | Aortic Valve | 3 | 2023 | 364 | 0.430 |
Why?
| | Time Factors | 9 | 2025 | 7134 | 0.430 |
Why?
| | Smoking Cessation | 3 | 2025 | 441 | 0.430 |
Why?
| | Aorta | 5 | 2024 | 441 | 0.430 |
Why?
| | Respiration, Artificial | 1 | 2019 | 714 | 0.420 |
Why?
| | Female | 31 | 2025 | 79045 | 0.420 |
Why?
| | Surgical Procedures, Operative | 2 | 2013 | 271 | 0.380 |
Why?
| | Catheters, Indwelling | 1 | 2013 | 96 | 0.370 |
Why?
| | Norwood Procedures | 2 | 2024 | 33 | 0.370 |
Why?
| | Heart Failure | 2 | 2024 | 2326 | 0.360 |
Why?
| | Aortic Stenosis, Supravalvular | 1 | 2012 | 4 | 0.360 |
Why?
| | Ethics, Medical | 1 | 2012 | 91 | 0.350 |
Why?
| | Coronary Sinus | 1 | 2012 | 9 | 0.350 |
Why?
| | Pulmonary Artery | 4 | 2024 | 1129 | 0.350 |
Why?
| | Peritoneal Dialysis | 1 | 2013 | 100 | 0.350 |
Why?
| | Esophageal Achalasia | 1 | 2012 | 29 | 0.340 |
Why?
| | Health Resources | 1 | 2013 | 130 | 0.340 |
Why?
| | Pericardium | 1 | 2012 | 59 | 0.340 |
Why?
| | Cardiopulmonary Bypass | 2 | 2025 | 219 | 0.340 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 67 | 0.340 |
Why?
| | Renal Insufficiency | 1 | 2013 | 172 | 0.330 |
Why?
| | Tobacco Products | 2 | 2022 | 84 | 0.330 |
Why?
| | Suture Techniques | 1 | 2011 | 137 | 0.320 |
Why?
| | Diagnostic Errors | 1 | 2012 | 178 | 0.320 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2012 | 198 | 0.310 |
Why?
| | Insurance, Health | 1 | 2013 | 311 | 0.310 |
Why?
| | Tricuspid Valve | 2 | 2025 | 43 | 0.300 |
Why?
| | Tetralogy of Fallot | 2 | 2020 | 78 | 0.290 |
Why?
| | Biomechanical Phenomena | 2 | 2024 | 860 | 0.290 |
Why?
| | Hospital Mortality | 2 | 2013 | 1038 | 0.280 |
Why?
| | Hypertension | 1 | 2017 | 1276 | 0.280 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5428 | 0.280 |
Why?
| | Magnetic Resonance Imaging, Cine | 4 | 2024 | 214 | 0.280 |
Why?
| | Adolescent | 8 | 2025 | 22577 | 0.260 |
Why?
| | Esophageal Neoplasms | 1 | 2012 | 348 | 0.260 |
Why?
| | Incidence | 5 | 2022 | 2934 | 0.260 |
Why?
| | Smokers | 2 | 2025 | 138 | 0.250 |
Why?
| | Lung | 2 | 2017 | 4116 | 0.240 |
Why?
| | Principal Component Analysis | 2 | 2024 | 194 | 0.240 |
Why?
| | Risk Factors | 7 | 2024 | 10919 | 0.240 |
Why?
| | Heart | 2 | 2020 | 626 | 0.220 |
Why?
| | Product Labeling | 2 | 2022 | 11 | 0.220 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2025 | 28 | 0.210 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 2 | 2023 | 45 | 0.210 |
Why?
| | Adenocarcinoma | 1 | 2012 | 926 | 0.210 |
Why?
| | Ventricular Function, Right | 2 | 2024 | 297 | 0.210 |
Why?
| | Scimitar Syndrome | 1 | 2024 | 10 | 0.210 |
Why?
| | Syndrome | 1 | 2025 | 381 | 0.200 |
Why?
| | Young Adult | 5 | 2025 | 14254 | 0.200 |
Why?
| | Electronic Nicotine Delivery Systems | 2 | 2025 | 110 | 0.200 |
Why?
| | Jugular Veins | 2 | 2022 | 42 | 0.200 |
Why?
| | Vaping | 1 | 2025 | 74 | 0.200 |
Why?
| | Age Factors | 2 | 2024 | 3346 | 0.200 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5993 | 0.200 |
Why?
| | Echocardiography, Doppler | 1 | 2024 | 115 | 0.200 |
Why?
| | Area Under Curve | 1 | 2024 | 332 | 0.200 |
Why?
| | Forecasting | 1 | 2025 | 390 | 0.190 |
Why?
| | United States | 6 | 2025 | 16126 | 0.190 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 41 | 0.190 |
Why?
| | Models, Cardiovascular | 2 | 2024 | 196 | 0.190 |
Why?
| | Vascular Resistance | 1 | 2024 | 370 | 0.190 |
Why?
| | Sternotomy | 1 | 2022 | 25 | 0.190 |
Why?
| | Calcinosis | 2 | 2023 | 234 | 0.180 |
Why?
| | Survival Rate | 2 | 2025 | 2094 | 0.180 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 115 | 0.170 |
Why?
| | Graft Survival | 1 | 2024 | 519 | 0.170 |
Why?
| | Fetal Diseases | 1 | 2023 | 194 | 0.170 |
Why?
| | Trachea | 2 | 2021 | 258 | 0.160 |
Why?
| | Socioeconomic Factors | 1 | 2025 | 1327 | 0.160 |
Why?
| | Warm Ischemia | 2 | 2017 | 19 | 0.160 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2024 | 390 | 0.150 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 481 | 0.150 |
Why?
| | Stents | 1 | 2024 | 564 | 0.150 |
Why?
| | Proteome | 1 | 2024 | 513 | 0.150 |
Why?
| | Cannula | 1 | 2018 | 28 | 0.140 |
Why?
| | Case-Control Studies | 3 | 2024 | 3634 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2024 | 835 | 0.140 |
Why?
| | Transcriptome | 1 | 2025 | 1042 | 0.140 |
Why?
| | Recurrence | 1 | 2021 | 1139 | 0.130 |
Why?
| | Prevalence | 1 | 2025 | 2875 | 0.130 |
Why?
| | Coronary Artery Disease | 1 | 2024 | 750 | 0.130 |
Why?
| | Smoking | 2 | 2022 | 1477 | 0.130 |
Why?
| | Umbilical Cord | 1 | 2017 | 93 | 0.130 |
Why?
| | Mice | 4 | 2025 | 18356 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4568 | 0.120 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 923 | 0.120 |
Why?
| | Animals | 7 | 2025 | 38102 | 0.120 |
Why?
| | Heart-Assist Devices | 2 | 2012 | 568 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3170 | 0.120 |
Why?
| | Biomarkers | 2 | 2024 | 4302 | 0.120 |
Why?
| | Reproducibility of Results | 1 | 2022 | 3418 | 0.100 |
Why?
| | Research Design | 1 | 2020 | 1139 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1711 | 0.100 |
Why?
| | Double-Blind Method | 1 | 2018 | 2064 | 0.100 |
Why?
| | Middle Aged | 9 | 2025 | 36309 | 0.100 |
Why?
| | Risk Assessment | 3 | 2019 | 3752 | 0.100 |
Why?
| | Quality of Life | 1 | 2026 | 3211 | 0.100 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5925 | 0.100 |
Why?
| | Aged | 7 | 2025 | 26217 | 0.090 |
Why?
| | Rural Health | 1 | 2013 | 87 | 0.090 |
Why?
| | Bronchiolitis Obliterans | 1 | 2013 | 61 | 0.090 |
Why?
| | Hospital Charges | 1 | 2013 | 46 | 0.090 |
Why?
| | Thymus Gland | 2 | 2024 | 312 | 0.090 |
Why?
| | Catheterization | 1 | 2013 | 184 | 0.090 |
Why?
| | Adult | 7 | 2025 | 40881 | 0.090 |
Why?
| | Risk Adjustment | 1 | 2013 | 85 | 0.090 |
Why?
| | Medically Uninsured | 1 | 2013 | 132 | 0.090 |
Why?
| | Cohort Studies | 4 | 2025 | 6033 | 0.090 |
Why?
| | Ventricular Fibrillation | 1 | 2012 | 64 | 0.090 |
Why?
| | Cryosurgery | 1 | 2012 | 46 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2601 | 0.090 |
Why?
| | Mitral Valve | 1 | 2012 | 95 | 0.090 |
Why?
| | Anxiety | 1 | 2019 | 1122 | 0.080 |
Why?
| | Sirolimus | 1 | 2013 | 282 | 0.080 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2012 | 222 | 0.080 |
Why?
| | Fatal Outcome | 1 | 2012 | 305 | 0.080 |
Why?
| | Blood Flow Velocity | 2 | 2024 | 421 | 0.080 |
Why?
| | Esophagectomy | 1 | 2012 | 135 | 0.080 |
Why?
| | Linear Models | 1 | 2013 | 849 | 0.080 |
Why?
| | Tachycardia, Ventricular | 1 | 2012 | 180 | 0.080 |
Why?
| | Logistic Models | 2 | 2013 | 2139 | 0.080 |
Why?
| | Medicare | 2 | 2013 | 904 | 0.080 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 343 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2013 | 456 | 0.070 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2012 | 237 | 0.070 |
Why?
| | Systole | 2 | 2020 | 181 | 0.070 |
Why?
| | Cattle | 1 | 2012 | 946 | 0.070 |
Why?
| | Radiography | 1 | 2012 | 853 | 0.070 |
Why?
| | Health Care Costs | 1 | 2012 | 425 | 0.070 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1547 | 0.070 |
Why?
| | Heart Valve Diseases | 1 | 2010 | 151 | 0.070 |
Why?
| | Prospective Studies | 2 | 2018 | 8078 | 0.070 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2011 | 221 | 0.070 |
Why?
| | Medicaid | 1 | 2013 | 467 | 0.070 |
Why?
| | Intensive Care Units | 1 | 2014 | 924 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1512 | 0.060 |
Why?
| | Stroke Volume | 2 | 2020 | 655 | 0.060 |
Why?
| | Databases, Factual | 1 | 2013 | 1491 | 0.060 |
Why?
| | Length of Stay | 1 | 2013 | 1350 | 0.060 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 528 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3916 | 0.060 |
Why?
| | Perfusion Imaging | 1 | 2024 | 66 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2023 | 4151 | 0.050 |
Why?
| | Organ Specificity | 1 | 2025 | 309 | 0.050 |
Why?
| | Prognosis | 1 | 2012 | 4330 | 0.050 |
Why?
| | Surgery, Computer-Assisted | 1 | 2024 | 85 | 0.050 |
Why?
| | Pulmonary Veins | 1 | 2024 | 108 | 0.050 |
Why?
| | Printing, Three-Dimensional | 1 | 2024 | 101 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 377 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 163 | 0.050 |
Why?
| | Virginia | 2 | 2014 | 57 | 0.050 |
Why?
| | Magnetic Resonance Angiography | 1 | 2024 | 251 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 118 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2010 | 874 | 0.050 |
Why?
| | Pulmonary Circulation | 1 | 2024 | 430 | 0.040 |
Why?
| | Swine | 1 | 2025 | 826 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2023 | 159 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 334 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 668 | 0.040 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 12 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 361 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2011 | 2770 | 0.040 |
Why?
| | Tobacco Use | 1 | 2021 | 62 | 0.040 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 38 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 45 | 0.040 |
Why?
| | Computer Simulation | 1 | 2024 | 1003 | 0.040 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2020 | 50 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 198 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 149 | 0.040 |
Why?
| | Regional Blood Flow | 1 | 2021 | 514 | 0.040 |
Why?
| | Blotting, Western | 1 | 2021 | 1184 | 0.030 |
Why?
| | Signal Transduction | 2 | 2023 | 5224 | 0.030 |
Why?
| | Myocardium | 1 | 2023 | 935 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1777 | 0.030 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 278 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1898 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2024 | 2050 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1998 | 0.030 |
Why?
| | Liver | 1 | 2025 | 1899 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 935 | 0.030 |
Why?
| | RNA | 1 | 2021 | 912 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2968 | 0.020 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 86 | 0.020 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 91 | 0.020 |
Why?
| | Citrates | 1 | 2012 | 41 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 65 | 0.020 |
Why?
| | Organ Preservation Solutions | 1 | 2012 | 46 | 0.020 |
Why?
| | Cost Savings | 1 | 2012 | 86 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 116 | 0.020 |
Why?
| | Cold Ischemia | 1 | 2012 | 40 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 419 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 134 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 269 | 0.020 |
Why?
| | Reoperation | 1 | 2014 | 637 | 0.020 |
Why?
| | Cold Temperature | 1 | 2012 | 206 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 251 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2012 | 544 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 390 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1261 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2012 | 356 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 644 | 0.020 |
Why?
| | Vasoconstrictor Agents | 1 | 2010 | 150 | 0.020 |
Why?
| | Risk | 1 | 2012 | 923 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 507 | 0.020 |
Why?
| | Survival Analysis | 1 | 2012 | 1378 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1300 | 0.020 |
Why?
| | Tissue Donors | 1 | 2012 | 420 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7216 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 203 | 0.020 |
Why?
| | Cell Movement | 1 | 2013 | 963 | 0.020 |
Why?
| | Heart Arrest | 1 | 2012 | 411 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 380 | 0.020 |
Why?
| | Odds Ratio | 1 | 2010 | 1083 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1217 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2012 | 1115 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6085 | 0.020 |
Why?
| | Contrast Media | 1 | 2010 | 497 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1330 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8347 | 0.010 |
Why?
|
|
Stone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|